Lanean...
Immunotherapy in Gynecologic Cancers: Are We There Yet?
Immune-targeted therapies have demonstrated durable responses in many tumor types with limited treatment options and poor overall prognosis. This has led to enthusiasm for expanding such therapies to other tumor types including gynecologic malignancies. The use of immunotherapy in gynecologic malign...
Gorde:
| Argitaratua izan da: | Curr Treat Options Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5936621/ https://ncbi.nlm.nih.gov/pubmed/28840453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-017-0504-y |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|